DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Kiessling P, Lledo-Garcia R, Watanabe S. , et al.
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study.
Sci Transl Med 2017;
9 (414) eaan1208
We do not assume any responsibility for the contents of the web pages of other providers.